LINDSAY POWELL: Open Payments
NPI 1285820738 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 65 payments from 18 companies in 2025. Trend: 2023 $664 · 2024 $1,152 · 2025 $1,349
Food & beverage: $1,234Education: $115
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $185 |
| Abbott Laboratories | 10 | $182 |
| SANOFI-AVENTIS U.S. LLC | 6 | $152 |
| Novo Nordisk Inc | 9 | $147 |
| Corcept Therapeutics | 5 | $109 |
| Insulet Corporation | 4 | $106 |
| Janssen Biotech, Inc. | 1 | $99 |
| Ascendis Pharma Endocrinology Inc | 3 | $50 |
| Radius Health, Inc. | 2 | $47 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $44 |
Products named: FREESTYLE LIBRE 3, TZIELD, Korlym, Omnipod, RYBREVANT, JARDIANCE, MOUNJARO, Ozempic.
Industry payments across SC — which companies pay providers there.
